Cytosorbents Corp (NASDAQ:CTSO)

7.70
Delayed Data
As of 4:00pm ET
 -0.05 / -0.65%
Today’s Change
3.30
Today|||52-Week Range
8.35
+18.46%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues4.1M4.8M9.5M15.2M
 
 
 
 
 
Cost of Goods Sold2.1M2.1M3.8M5.3M
 
 
 
 
 
Depreciation And Amortization65.5K113.0K161.6K218.3K
 
 
 
 
 
 
Operating ExpensesGross Income2.0M2.6M5.6M9.6M
 
 
 
 
 
General Expenses9.3M11.9M17.1M19.5M
 
 
 
 
 
Research And Development2.4M3.9M4.8M4.0M
 
 
 
 
 
Total Operating Expenses11.4M14.1M21.0M25.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.3M-9.3M-11.5M-9.8M
 
 
 
 
 
Extraordinary Credit--1.3M0.000.00
 
 
Extraordinary Charge-2.1M0.00-175.4K0.00
 
 
 
Interest Expense On Debt310.0K0.00231.8K749.1K
 
 
 
 
Other Expenses0.00-507.3K-358.1K1.5M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.7M-8.5M-12.3M-9.1M
 
 
 
 
 
Income Taxes-385.6K-324.6K-318.6K-676.7K
 
 
 
 
 
Preferred Dividend-9.3M0.000.00-335.7K
 
 
 
Net Income-9.3M-8.1M-11.9M-8.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS14.4M24.9M25.4M27.6M
 
 
 
 
 
Shares To Calculate EPS Diluted14.4M24.9M25.4M27.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.29-$0.33-$0.47-$0.32
 
 
 
 
 
EPS Diluted-$1.29-$0.33-$0.47-$0.32